Role of tissue-type plasminogen activator in salicylic acid-induced sloughing of human corn tissue

Journal of the American Podiatric Medical Association

Volumn 98, Issue 5, 2008, Pages 345-352

  Heda, Ghanshyam D ^a,b   Roberts, Lee K ^c,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MISSISSIPPI UNIVERSITY FOR WOMEN   (United States)

^c ODC Therapy Inc   (United States)

^d MUW 100 ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53649085905     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0980345     Document Type: Article

References (54)

1. BIZZOZERO G: Sulla struttura degli epiteli pavimentosi stratificati [abstract]. Zentral Medizinisches Wochenschrift 9: 482, 1871.
2. STAEHELIN LA: Structure and function of intercellular junctions. Int Rev Cytol 39: 191, 1974.
3. CHAPMAN SJ, WALSH A: Desmosomes, corneosomes and desquamation: an ultra structural study of adult pig epidermis. Arch Dermatol Res 282: 304, 1990.
4. ELIAS PM, GRAYSON S, LAMPE MA, ET AL: "The Intercorneocyte Space," in Stratum Corneum, ed by R Marks, G Plewig, p 53, Springer-Verlag, Berlin-Heidelberg, 1986.
5. BIDMEAD MC, RODGER ML: The effect of enzymes on stratum corneum. J Soc Cosmet Chem 24: 493, 1973.
6. BJELLAND S, GILDBERG A, VOLDEN G: Degradation of human epidermal keratin by fish pepsin. Dermatol Res 280: 119, 1988.
7. LUNDSTROM A, EGELRUD T: Stratum corneum chymotryptic enzyme: a proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation. Acta Derm Venereol 71: 471, 1991.
8. EGELRUD T, HOFER P-A, LUNDSTROM A: Proteolytic degradation of desmosomes in plantar stratum corneum leads to cell dissociation in vitro. Acta Derm Venereol 68: 93, 1988.
9. DANO K, ANDREASEN J, GRONDAHL-HANSEN J, ET AL: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 140, 1985.
10. MCCARTHY DJ, HABOWSKY JE: Histochemistry and anthropometric analysis of heloma durum. JAPA 65: 4, 1975.
11. HASHIMOTO K, WUN TC, BAIRD J, ET AL: Keratinocyte inhibitors of plasminogen activator: characterization and ability to prevent pemphigus IgG induced acantholysis. J Invest Dermatol 92: 310, 1989.
12. SINGER KH, HASHIMOTO K, LAZARUS GS: Antibody-induced proteinase activation: a proposed mechanism for pemphigus. Springer Semin Immunopathol 4: 17, 1981.
13. JENSEN PJ, JOHN M, BAIRD J: Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187: 162, 1990.
14. ISSEROFF RR, FUSENIG NE, RIFKIN DB: Plasminogen activator in differentiating mouse keratinocytes. J Invest Dermatol 80: 217, 1983.
15. CLARK RAF, LANIGAN JM, DELLAPELLE P, ET AL: Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 79: 264, 1982.
16. GRONDAHL-HANSEN J, OTTEVANGER V: Tissue-type plasminogen activator concentrations in plasma from patients with psoriasis. Acta Derm Venereol 69: 391, 1989.
17. LOTTI T, BONAN P, PANCONESI E: Plasminogen activation in psoriasis. Acta Derm Venereol Suppl 146: 36, 1989.
18. GRANDO SA: Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. J Dermatol Sci 4: 95, 1992.
19. SIER CFM, VERSPAGET HW, GRIFFIOEN G, ET AL: Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Gastroenterology 101: 1522, 1991.
20. REILLY D, CHRISTENSEN L, DUCH M, ET AL: Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer 50: 208, 1992.
21. NAGAYAMA M, SATO A, HAYAKAWA H, ET AL: Plasminogen activators and their inhibitors in non-small cell lung cancer: low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer 71: 1398, 1994.
22. SWINEHART JM: Salicylic acid ointment peeling of the hands and forearms. Effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol 18: 495, 1992.
23. PARISH LC, MONROE E, REX IH: Treatment of common warts with high-potency (26%) salicylic acid. Clin Ther 10: 462, 1988.
24. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ, ET AL: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5249, 1979.
25. SAMBROUK J, FRITCH EF, MANIATIS T: Molecular Cloning: A Laboratory Manual, p 7.43, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
26. PENNICA D, HOLMES WE, KOHR WJ, ET AL: Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301: 214, 1983.
27. VERDE P, STOPPELLI MP, GALEFFI P, ET AL: Identification and primary sequence of an unspliced human urokinase poly (A)+ RNA. Proc Natl Acad Sci U S A 81: 4727, 1984.
28. GINSBURG D, ZAHEB R, YANG AY, ET AL: cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 78: 1673, 1986.
29. SCHLEUNING WD, MEDCALF RL, HESSION C, ET AL: Plasminogen activator inhibitor-2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol 7: 4564, 1987.
30. ERBA HP, EDDY R, SHOWS T, ET AL: Structure, chromosome location, and expression of the human γ-actin gene: differential evolution, location, and expression of the cytoskeletal β- and γ-actin genes. Mol Cell Biol 8: 1775, 1988.
31. LUNA LG: "Manual of Histologic Staining," in Methods of the Armed Forces Institute of Pathology, 3rd Ed, Mc-Graw-Hill, New York, 1968.
32. LAZARUS GS, JENSEN PJ: Plasminogen activators in epithelial biology. Semin Thromb Hemost 17: 210, 1991.
33. CHEN CS, LYONS-GIORDANO B, LAZARUS GS, ET AL: Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. J Cell Sci 106: 45, 1993.
34. LYONS-GIORDANO B, LAZARUS GS: Skin abnormalities in mice transgenic for plasminogen activator inhibitor 1: implications for the regulation of desquamation and follicular neogenesis by plasminogen activator enzymes. Dev Biol 170: 289, 1995.
35. LUNDSTROM A, EGELRUD T: Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I. J Invest Dermatol 94: 216, 1990.
36. LUNDSTROM A, EGELRUD T: Cell shedding from human plantar skin in vitro: evidence that two different types of protein structures are degraded by a chymotrypsinlike enzyme. Arch Dermatol Res 282: 234, 1990.
37. EGELRUD T, LUNDSTROM A: A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch Dermatol Res 283: 108, 1991.
38. SUZUKI Y, NOMURA J, HORI J, ET AL: Detection and characterization of endogenous protease associated with desquamation of stratum corneum. Arch Dermatol Res 285: 372, 1993.
39. IMAI S: The effect of the proteolytic enzyme savinase on plantar skin in vitro. Arch Dermatol Res 283: 377, 1991.
40. KASHIMA M, FUKUYAMA K, KIKUCHI M, ET AL: Limited proteolysis of high molecular weight histidine-rich protein of rat epidermis by epidermal proteinases. J Invest Dermatol 90: 829, 1988.
41. ASTRUP T: "Cell Induced Fibrinolysis: A Fundamental Process," in Cold Spring Harbor Conference on Cell Proliferation, Vol 2, ed by E Reich, DB Rifkin, E Shaw, p 343, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1975.
42. HIBINO T, IZAKI S, OHKUMA M, ET AL: Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2. FEBS Lett 231: 202, 1988.
43. SPIERS EM, LAZARUS GS, LYONS-GIORDANO B: Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102: 333, 1994.
44. SCHILTZ JR, HU C, MICHEL B: Pemphigus antibody interaction with human epidermal cells in culture: a proposed mechanism for pemphigus acantholysis. J Clin Invest 62: 778, 1978.
45. HASHIMOTO K, SHAFRAN KM, WEBBER PS, ET AL: Anti-cell surface pemphigus auto antibody stimulates plasminogen activator activity of human epidermal cells: a mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157: 259, 1983.
46. FARB RM, DYKES R, LAZARUS GS: Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci U S A 75: 459, 1978.
47. MORIOKA S, NAITO K, OGAWA H: The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol 76: 337, 1981.
48. BAIRD J, LAZARUS GS, BELIN D, ET AL: mRNA for tissuetype plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95: 548, 1990.
49. GISSLER HM, FRANK R, KRAMER MD: Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Br J Dermatol 128: 612, 1993.
50. SERRE G, MILS V, HAFTEK M, ET AL: Identification of late differentiation antigens of human cornified epithelia, expressed in re-organized desmosomes and bound to cross-linked envelope. J Invest Dermatol 97: 106, 1991.
51. DAVIES M, MARKS M: Studies on the effect of salicylic acid on normal skin. Br J Dermatol 95: 187, 1976.
52. HUBER C, CHRISTOPHER E: "Keratolytic" effect of salicylic acid. Arch Derm Res 257: 293, 1977.
53. PAUNESKU T, CHANG-LIU CM, SHEARIN- JONES P, ET AL: Identification of genes regulated by UV/salicylic acid. Int J Radiat Biol 76: 189, 2000.
54. ROBBINS KC: "Fibrinolysis," in Thrombosis, ed by HC Kwaan, EJW Bowie, p 23, WB Saunders, Philadelphia, 1982.